Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write
Rukunan Magani
Magungunan da aka Fi So

Wani mutum daga Indiya mai himma yana fama da cutar kansar ciki

Suna: THIRANDAS SHIVA PRASAD

Jinsi:Namiji

Shekaru: 32

Ƙasa: 'Yan Indiya

Ganewar asali: Ciwon daji na ciki

    Akwai wani mutum mai juriya mai suna Thirandas Shiva Prasad. Yana da shekaru 32, kuma ya fito daga Indiya. Me ya sa muke nuna jajircewarsa? Ga labarinsa mai ban mamaki.

    An gano Thirandas yana da ciwon daji na ciki a shekarar 2023, inda ya nuna ciwon ciki kuma an tabbatar da shi a matsayin adenocarcinoma na ƙananan ƙwayoyin cuta. An yi masa maganin neoadjuvant chemotherapy tare da tsarin FLOT, sannan aka yi masa tiyata ciki har da tiyatar ciki. Duk da jiyya bayan tiyata, ciwon ya sake dawowa tare da metastases zuwa ƙashin ƙugu, wanda ke haifar da matsaloli kamar hydronephrosis, ƙuraje, da toshewar ciki. Ya jure wa jiyya da yawa, ciki har da dialysis, stenting, da ƙarin chemo tare da nab-paclitaxel, nivolumab, irinotecan, da sauransu. Nan da shekarar 2025, gwajin PET-CT ya nuna ci gaba tare da ƙaruwar raunuka na ciki da ascites, wanda ya bar shi yana buƙatar zaɓuɓɓuka masu ƙirƙira.

    Don neman kulawa ta zamani, Thirandas ya koma BIOOCUS. Ƙungiyar ƙwararrunmu ta bayar da kimantawa ta farko kyauta, tana duba tarihinsa mai zurfi kuma tana ba da shawarar maganin ƙwayoyin CLDN18.2 CAR-T, wanda aka tsara shi daidai da yanayin ciwon kansa. Bayan an yi masa magani kafin a fara amfani da shi, an yi amfani da jiko cikin sauƙi a cikin cibiyarmu mai ci gaba. Duk da ƙalubalen farko kamar zazzabi da yiwuwar kamuwa da cuta, ƙungiyarmu ta fannoni daban-daban ta magance alamun yadda ya kamata ta amfani da maganin rigakafi da kulawa mai ƙarfi, ta tabbatar da cewa babu CRS mai tsanani. An magance hanyoyin kamar magudanar ruwa a ciki da gyaran stent daidai gwargwado, wanda ya haifar da rage alamun cutar da kuma sakamako mai kyau bayan an yi masa magani.

    BIOOCUS ta yi fice saboda ingantaccen sabis ɗinta da samfuran kirkire-kirkire. Maganinmu na CAR-T, wanda ke mai da hankali kan CLDN18.2, yana ba da hari mai niyya ga ƙwayoyin cutar kansa, sau da yawa yana samun nasara inda magungunan gargajiya suka gaza. Ayyukan marasa lafiya sun yi fice wajen daidaita tafiye-tafiye na ƙasashen waje, suna ba da fahimtar al'adu, da kuma bayar da cikakken bin diddigi, duk ba tare da ƙarin nauyi ba. Thirandas yana yaba wa ma'aikatan tausayi da ingantattun hanyoyin da suka mayar da wata ƙwarewa mai ban tsoro zuwa ga bege.

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write